Cargando…
Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
Epilepsy is a frequent, chronic disease demanding long-term medication with antiepileptic drugs (AEDs). When slow release formulations of AEDs are used the chance of compliance and control of seizures is increased. Lamotrigine (LTG) is a broad spectrum antiepileptic drug (AED), effective against bot...
Autores principales: | Błaszczyk, Barbara, Czuczwar, Stanisław J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874338/ https://www.ncbi.nlm.nih.gov/pubmed/20505846 |
Ejemplares similares
-
Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
por: Werz, Mary Ann
Publicado: (2008) -
Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
por: Miziak, Barbara, et al.
Publicado: (2021) -
Successful management of massive lamotrigine extended‐release intoxication in a dog
por: McLaine, Alexis S., et al.
Publicado: (2021) -
Epilepsy in Pregnancy—Management Principles and Focus on Valproate
por: Błaszczyk, Barbara, et al.
Publicado: (2022) -
Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model – Phenytoin and Valproate, Lamotrigine and Valproate
por: Taing, Kim Det, et al.
Publicado: (2017)